Friday, July 31, 2026

PIXELL by 4By4 Lands on AWS Marketplace, Goes Global

4By4 lists its image enhancement AI, PIXELL, on AWS Marketplace, expanding global reach for advanced image quality solutions.

Celltrion’s ‘Psoriasis’ Biosimilar Poised to Challenge Big Pharma with Phase 1 Data

The EADV conference in Paris showcased Celltrion's biosimilar CT-P55, confirming its equivalence to Cosentyx in safety and pharmacokinetics.

Pyongyang’s International Marathon Returns After COVID Pause

North Korea promotes the Pyongyang International Marathon set for April 6, but doubts linger due to past cancellations and conflicting dates.

Tag: ASCO

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Sillajen Presents Early BAL0891 Clinical Findings at ASCO 2026, Highlighting Safety and Early Anti-Cancer Activity

ShillaGen presented initial clinical research results of its cancer drug BAL0891 at ASCO, showcasing promising developments.

SillaJen’s Breakthrough Cancer BAL0891 Drug Set for ASCO 2026 Reveal

SillaJen's anticancer drug BAL0891 will be presented at the ASCO Annual Meeting, currently in Phase 1 trials for solid tumors and AML.

Cancer Gone for 3 Years? This New Drug Is Making It Happen

AbbVie's Epkinly shows 96% long-term complete remission in R/R large B-cell lymphoma patients, highlighting its effectiveness as a therapy.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.